About this trial

This is a prospective cohort study to explore the differences of serum indicators between elderly gastrointestinal neoplasms patients with postoperative delirium (POD) who either develop or do not develop long-term postoperative neurocognitive disorders (pNCD).

Eligibility criteria

Qualifiers

Patients ≥65 years of age who have undergone surgical anesthesia of gastrointestinal neoplasms; Sign informed consent.

Disqualifiers

Inability to complete cognitive function assessment; Illiteracy, hearing impairment or visual impairment; He has a history of epilepsy, depression, schizophrenia, Alzheimer's disease and other psychiatric and neurological diseases.

Trial design

Treatments tested in this trial

  • no intervention

Treatment groups

165 Participants
are divided into 1 treatment group

Locations

1
Xuanwu Hospital, Capital Medical University100053, Beijing China

Sponsors and collaborators

Xuanwu Hospital, Beijing

Lead sponsor